My husband Ralph is in his 4th day of a First In Human clinical trial at NIH.  He is patient #3.  My last update was Day zero:  T-Cell Infusion Day.

So far, so good.  Everyone is pleasantly surprised how well he is tolerating the IL2.

Today during morning rounds Ralph had another room full of doctors. Thursdays are what they call “Grand Rounds” meaning EVERYONE makes rounds together on patients including doctors, nurses, unit administration, pharmacist, social worker, etc. The main doctor on the trial usually does not round daily, the attending physician rounds and then reports back. We’re told that everyone on the team is in the loop at all times.  There is constant communication among all the members.

Dr. Childs is the main doctor and principal investigator of this trial.  He is  very pleased with Ralph’s progress on the trial.  His labs are good and he’s tolerating the IL2 infusions better than expected. He received his 7th IL2 infusion today at noon, only 7 more to go.  IL2 is called the food for the T-cells.

Later in the afternoon, his nurse noticed that one arm looked swollen.  They took an ultrasound and determined that he has a clot in each arm.  He will now go on Heperin, an anti-coagulant.  Dr. Childs reassured Ralph this is not a big deal and will not interfere with the trial protocol.

Thus far from our experience at NIH, Ralph has received excellent care.  Although at times I think he feels like he’s under a microscope.  But let’s not forget why he is here, to hopefully find a cure and to advance science for all mankind.  After all, NIH could also stand for National Institutes of HOPE.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Deb Beyhan is the Patient Legislative Advocate for KidneyCAN. She was diagnosed with stage IV kidney cancer in 2016 at the age of 53. Deb lives outside of Atlanta, GA, with her husband.    For this month's Community Spotlight, we want to tell you about a member of our volunteer team, Deb Beyhan....

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

District Days: Asking Congress to Fund Kidney Cancer Research

District Days: Asking Congress to Fund Kidney Cancer Research

On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

The 2022 Kidney Cancer Research Summit

The 2022 Kidney Cancer Research Summit

Dr. Laurence Albiges (Institut Gustave Roussy) presents on the microbiome at KCRS22. The microbiome has now been recognized as one of the emerging hallmarks and enabling characteristics of cancer. KidneyCAN hosted the 4th Annual Kidney Cancer Research Summit on October 6-7, 2022  live in...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Rock the Run for Kidney Cancer Research Funding

Rock the Run for Kidney Cancer Research Funding

KidneyCAN had the first ever Rock the Run 5k fundraiser in October 2022. This is part of the group of KCRS22 attendees who walked and ran with us at dawn before the second conference day began. KidneyCAN is proud to share the results of the first annual Rock the Run 5K fundraiser. Our Purpose...